1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine

C29H16N2O — CID 122471130

IUPAC1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine
SMILESc1ccc2c(c1)oc1c(-c3ccc4c5cccc6c7ccccc7n(c4c3)c65)nccc12
InChIInChI=1S/C29H16N2O/c1-3-10-24-18(6-1)21-8-5-9-22-19-13-12-17(16-25(19)31(24)28(21)22)27-29-23(14-15-30-27)20-7-2-4-11-26(20)32-29/h1-16H
InChIKeyWTENVXAKPSKVQB-UHFFFAOYSA-N
MW408.46 g/mol
LogP7.80
Rot. Bonds1

About 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine

1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine (PubChem CID 122471130) has the molecular formula C29H16N2O and a molecular weight of 408.46 g/mol. Its IUPAC name is 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine.

Molecular Properties

Compound Name1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine
PubChem CID122471130
Molecular FormulaC29H16N2O
Molecular Weight408.46 g/mol
Exact Mass408.13
IUPAC Name1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine
SMILESc1ccc2c(c1)oc1c(-c3ccc4c5cccc6c7ccccc7n(c4c3)c65)nccc12
InChIInChI=1S/C29H16N2O/c1-3-10-24-18(6-1)21-8-5-9-22-19-13-12-17(16-25(19)31(24)28(21)22)27-29-23(14-15-30-27)20-7-2-4-11-26(20)32-29/h1-16H
InChIKeyWTENVXAKPSKVQB-UHFFFAOYSA-N
XLogP7.80
TPSA30.44 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds1
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500408.46
LogP ≤ 57.80
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Analyze 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine?
The IUPAC name of 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine (CID 122471130) is 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine.
What is the SMILES notation for 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine?
The canonical SMILES for 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine is c1ccc2c(c1)oc1c(-c3ccc4c5cccc6c7ccccc7n(c4c3)c65)nccc12.
What is the InChIKey of 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine?
The InChIKey is WTENVXAKPSKVQB-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H16N2O/c1-3-10-24-18(6-1)21-8-5-9-22-19-13-12-17(16-25(19)31(24)28(21)22)27-29-23(14-15-30-27)20-7-2-4-11-26(20)32-29/h1-16H.
What are the key properties of 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine?
1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine has a molecular weight of 408.46 g/mol, XLogP of 7.80, 1 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1-azapentacyclo[10.6.1.02,7.08,19.013,18]nonadeca-2(7),3,5,8,10,12(19),13,15,17-nonaen-4-yl)-[1]benzofuro[2,3-c]pyridine is sourced from PubChem (CID 122471130), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).